Related Experiment Video

Updated: Aug 9, 2026

Real Time Measurements of Membrane Protein:Receptor Interactions Using Surface Plasmon Resonance (SPR)
09:35

Real Time Measurements of Membrane Protein:Receptor Interactions Using Surface Plasmon Resonance (SPR)

Published on: November 29, 2014

Model-independent method of analyzing input in linear pharmacokinetic systems having polyexponential impulse response

P V Pedersen

    Journal of Pharmaceutical Sciences
    |March 1, 1980
    PubMed

    More Related Videos

    Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs10:02

    Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

    Published on: July 23, 2016

    Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging11:43

    Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging

    Published on: December 30, 2016

    Related Concept Videos

    Analysis of Population Pharmacokinetic Data01:12

    Analysis of Population Pharmacokinetic Data

    Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
    Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

    Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

    Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
    The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
    Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

    Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

    Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
    One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
    Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model01:13

    Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model

    Drugs administered through various routes can lead to nonlinear elimination, resulting in complex pharmacokinetic behaviors crucial to understanding efficacious drug dosing.
    When a drug is administered through a constant intravenous infusion and eliminated via nonlinear pharmacokinetics, it follows zero-order input. For example, oral drugs undergo first-order absorption upon administration and are eliminated through nonlinear pharmacokinetics.
    In the case of subcutaneously administered drugs,...
    Pharmacodynamic Models: Linear Concentration–Effect Model01:15

    Pharmacodynamic Models: Linear Concentration–Effect Model

    The linear concentration–effect model, underpinned by the principle that pharmacological effect (E) is directly proportional to plasma drug concentration (C), emerges as a pivotal simplification of the Emax model for conditions where C is significantly less than EC50. This model portrays a linear trajectory of the concentration–effect relationship when drug levels are markedly below the EC50 threshold.Despite its inherent assumption of continuous effect augmentation with increasing drug...
    Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model01:14

    Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model

    The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A higher...